Effects of human Toll-like receptor 1 polymorphisms on ageing

Immunity and Ageing

Volumn 10, Issue 1, 2013, Pages

  Uciechowski, Peter ^a   Oellig, Eva Maria ^a   Mariani, Erminia ^b   Malavolta, Marco ^c   Mocchegiani, Eugenio ^c   Rink, Lothar ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INRCA   (Italy)

Author keywords

Ageing; CCL2; Cytokines; IL 1Ra; Nonagenarians; SNP; TLR1

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; GERMANY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUPERNATANT; TUBERCULOSIS;

EID: 84873395357     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/1742-4933-10-4     Document Type: Article

References (57)

1. Grubeck-Loebenstein B, Della Bella S, Iorio AM, Michel JP, Pawelec G, Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res 2009, 21:201-209.
2. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panouraia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007, 128:92-105. 10.1016/j.mad.2006.11.016, 17116321.
3. Beutler B. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 2009, 227:248-263. 10.1111/j.1600-065X.2008.00733.x, 2713013, 19120489.
4. Coll RC, O'Neill LAJ. New insights into the regulation of signalling by toll-like receptors and Nod-like receptors. J Innate Immun 2010, 2:406-421. 10.1159/000315469, 20505309.
5. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995. 10.1038/ni1112, 15454922.
6. Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010, 32:305-315. 10.1016/j.immuni.2010.03.012, 20346772.
7. Kumagai Y, Akira S. Identification and functions of pattern-recognition receptors. J Allergy Clin Immunol 2010, 125:985-992. 10.1016/j.jaci.2010.01.058, 20392481.
8. Uciechowski P, Imhoff H, Lange C, Meyer CG, Browne EN, Kirsten DK, Schroeder AK, Schaaf B, Al Lahham A, Reinert RR, Reiling N, Haase H, Hatzmann A, Fleischer D, Heussen N, Kleines M, Rink L. Susceptibility to tuberculosis is associated with TLR1 polymorphisms resulting in a lack of TLR1 cell surface expression. J Leukoc Biol 2011, 90:377-388. 10.1189/jlb.0409233, 21642391.
9. Krutzik SR, Modlin RL. The role of Toll-like receptors in combating mycobacteria. Sem Immunol 2004, 16:35-41.
10. Schaaf HS, Collins A, Bekker A, Davies PDO. Tuberculosis at extremes of age. Respirology 2010, 15:747-763. 10.1111/j.1440-1843.2010.01784.x, 20546192.
11. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong ZY, Modlin RL, Akira S. Cutting edge: role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002, 169:10-14.
12. Ma X, Liu YH, Gowen BB, Graviss EA, Clark AG, Musser JM. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One 2007, 2:e1318. 10.1371/journal.pone.0001318, 2117342, 18091991.
13. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin C, Alpsoy E, Hamann L, Schumann RR, Tapping RI. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 2007, 178:7520-7524.
14. Wyllie DH, Kiss-Toth E, Visintin A, Smith SC, Boussouf S, Segal DM, Duff GW, Dower SK. Evidence for an accessory protein function for toll-like receptor 1 in anti-bacterial responses. J Immunol 2000, 165:7125-7132.
15. Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lans NTN, Quy HT, Chau TTH, Rodrigues S, Nachman A, Janer M, Hien TT, Farrar JJ, Aderem A. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 2007, 37:2280-2289. 10.1002/eji.200737034, 17595679.
16. Schumann RR, Tapping RI. Genomic variants of TLR1 - It takes (TLR-)two to tango. Eur J Immunol 2007, 37:2059-2062. 10.1002/eji.200737604, 17654751.
17. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired toll-like receptor expression and function in aging. J Immunol 2002, 169:4697-4701.
18. Boehmer ED, Meehan MJ, Cutro BT, Kovacs EJ. Aging negatively skews macrophage TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway. Mech Ageing Dev 2005, 126:1305-1313. 10.1016/j.mad.2005.07.009, 16154177.
19. Fulop T, Larbi A, Douziech N, Fortin C, Guerard KP, Lesur O, Khalil A, Dupuis G. Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004, 3:217-226. 10.1111/j.1474-9728.2004.00110.x, 15268755.
20. Gleeson M, McFarlin B, Flynn M. Exercise and toll-like receptors. Exercise Immunol Rev 2006, 12:34-53.
21. Panda A, Arjona A, Sapey E, Bai FW, Fikrig E, Montgomery RR, Lord JM, Shaw AC. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009, 30:325-333. 10.1016/j.it.2009.05.004, 19541535.
22. Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM. Aging of the innate immune system. Curr Opin Immunol 2010, 22:507-513. 10.1016/j.coi.2010.05.003, 20667703.
23. Shaw AC, Panda A, Joshi SR, Qian F, Allore HG, Montgomery RR. Dysregulation of human Toll-like receptor function in aging. Ageing Res Rev 2011, 10:346-353. 10.1016/j.arr.2010.10.007, 21074638.
24. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, Allore HG, Montgomery RR, Shaw AC. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010, 184:2518-2527. 10.4049/jimmunol.0901022, 20100933.
25. van Duin D, Mohanty S, Thomas V, Ginter S, Montgomery RR, Fikrig E, Allore HG, Medzhitov R, Shaw AC. Age-associated defect in human TLR-1/2 function. J Immunol 2007, 178:970-975.
26. Schroeder AK, van der Ohe M, Fleischer D, Rink L, Uciechowski P. Differential synthesis of two interleukin-1 receptor antagonist variants and interleukin-8 by peripheral blood neutrophils. Cytokine 2005, 32:246-253. 10.1016/j.cyto.2005.10.004, 16343927.
27. Jylha M, Paavilainen P, Lehtimaki T, Goebeler S, Karhunen PJ, Hervonen A, Hurme M. Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90 + study. J Gerontol A Biol Sci Med Sci 2007, 62:1016-1021. 10.1093/gerona/62.9.1016, 17895441.
28. Kahmann L, Uciechowski P, Warmuth S, Plümäkers B, Gressner AM, Malavolta M, Mocchegiani E, Rink L. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res 2008, 11:227-237. 10.1089/rej.2007.0613, 18279033.
29. Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, Guralnik JM, Longo DL. The origins of age-related proinflammatory state. Blood 2005, 105:2294-2299. 10.1182/blood-2004-07-2599, 15572589.
30. Gerli R, Monti D, Bistoni O, Mazzone AM, Peri G, Cossarizza A, Di Gioacchino M, Cesarotti MEF, Doni A, Mantovani A, Franceschi C, Paganelli R. Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev 2000, 121:37-46.
31. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004, 39:687-699. 10.1016/j.exger.2004.01.009, 15130663.
32. Mariani E, Cattini L, Neri S, Malavolta M, Mocchegiani E, Ravaglia G, Facchini A. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. Biogerontology 2006, 7:449-459. 10.1007/s10522-006-9060-8, 16967203.
33. Tiainen K, Hurme M, Hervonen A, Luukkaala T, Jylha M. Inflammatory markers and physical performance among nonagenarians. J Gerontol A Biol Sci Med Sci 2010, 65:658-663.
34. Bruunsgaard H. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Network 2002, 13:389-391.
35. Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK. Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 2003, 132:24-31. 10.1046/j.1365-2249.2003.02137.x, 1808682, 12653832.
36. Gomez CR, Nomellini V, Faunce DE, Kovacs EJ. Innate immunity and aging. Exp Gerontol 2008, 43:718-728. 10.1016/j.exger.2008.05.016, 2564282, 18586079.
37. Schroder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005, 5:156-164.
38. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen RT, Medzhitov R, Fikrig E, Flavell RA. Hyporesponsiveness to vaccination with borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med 2002, 8:878-884.
39. van Duin D, Shaw AC. Toll-like receptors in older adults. J Am Geriatr Soc 2007, 55:1438-1444. 10.1111/j.1532-5415.2007.01300.x, 17767688.
40. Pino-Yanes M, Corrales A, Casula M, Blanco J, Muriel A, Espinosa E, Garcia-Bello M, Torres A, Ferrer M, Zavala E, Villar J, Flores C. Common variants of TLR1 associate with organ dysfunction and sustained Pro-inflammatory responses during sepsis. PLoS One 2010, 5:e13759. 10.1371/journal.pone.0013759, 2966434, 21048935.
41. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, Mullerhermelink HK, Steinmann GG. Admission criteria for immunogerontological studies in Man - the senieur protocol. Mech Ageing Dev 1984, 28:47-55. 10.1016/0047-6374(84)90152-0, 6513613.
42. Balistreri CR, Candore G, Colonna-Romano G, Lio D, Caruso M, Hoffmann E, Franceschi C, Caruso C. Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 2004, 292:2339-2340. 10.1001/jama.292.19.2339, 15547160.
43. Roubenoff R, Harris TB, Abad LW, Wilson PWF, Dallal GE, Dinarello CA. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci 1998, 53:M20-M26.
44. Stowe RP, Peek MK, Cutchin MP, Goodwin JS. Plasma cytokine levels in a population-based study: relation to Age and ethnicity. J Gerontol A Biol Sci Med Sci 2010, 65:429-433. 2844059, 20018825.
45. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, Listi F, Nuzzo D, Lio D, Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007, 128:83-91. 10.1016/j.mad.2006.11.015, 17118425.
46. Haase H, Mocchegiani E, Rink L. Correlation between zinc status and immune function in the elderly. Biogerontology 2006, 7:421-428. 10.1007/s10522-006-9057-3, 16953331.
47. Marcellini F, Giuli C, Papa R, Gagliardi C, Dedoussis G, Herbein G, Fulop T, Monti D, Rink L, Jajte J, Mocchegiani E. Zinc status, psychological and nutritional assessment in old people recruited in five European countries: zincage study. Biogerontology 2006, 7:339-345. 10.1007/s10522-006-9048-4, 16969711.
48. Sandmand M, Bruunsgaard H, Kemp K, Andersen-Ranberg K, Schroll M, Jeune B. High circulating levels of tumor necrosis factor-alpha in centenarians are not associated with increased production in T lymphocytes. Gerontology 2003, 49:155-160. 10.1159/000069174, 12679605.
49. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Ferrannini E, Serio M. Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. J Interferon Cytokine Res 2005, 25:547-552. 10.1089/jir.2005.25.547, 16181055.
50. Gabriel P, Cakman I, Rink L. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp Gerontol 2002, 37:235-247. 10.1016/S0531-5565(01)00189-9, 11772509.
51. Seidler S, Zimmermann HW, Bartneck M, Trautwein C, Tacke F. Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol 2010, 11:30. 10.1186/1471-2172-11-30, 2910032, 20565954.
52. Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007, 97:714-721.
53. Song Y, Shen H, Schenten D, Shan PY, Lee PJ, Goldstein DR. Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2012, 32:103-U267. 10.1161/ATVBAHA.111.236349, 3241880, 22034510.
54. Deo R, Khera A, McGuire DK, Murphy SA, Neto JDPM, Morrow DA, de Lemos JA. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004, 44:1812-1818. 10.1016/j.jacc.2004.07.047, 15519012.
55. Haase H, Rink L. The immune system and the impact of zinc during aging. Immun Ageing 2009, 6:9. 10.1186/1742-4933-6-9, 2702361, 19523191.
56. Mocchegiani E, Costarelli L, Giacconi R, Piacenza F, Basso A, Malavolta M. Zinc, metallothioneins and immunosenescence: effect of zinc supply as nutrigenomic approach. Biogerontology 2011, 12:455-465. 10.1007/s10522-011-9337-4, 21503725.
57. Balistreri CR, Colonna-Romano G, Lio D, Candore G, Caruso C. TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol 2009, 29:406-415. 10.1007/s10875-009-9297-5, 19459036.